Novel Imidazopyridine and Imidazopyridazine Derivatives as DGAT2 Inhibitors for Treating Multiple Diseases.

ACS Med Chem Lett

Smith, Gambrell & Russell LLP, 1105 W. Peachtree Street NE, Suite 1000, Atlanta, Georgia 30309, United States.

Published: August 2024

Provided herein are novel imidazopyridine and imidazopyridazine derivatives as DGAT2 inhibitors, pharmaceutical compositions, use of such compounds in treating multiple diseases, and processes for preparing such compounds.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11318096PMC
http://dx.doi.org/10.1021/acsmedchemlett.4c00286DOI Listing

Publication Analysis

Top Keywords

novel imidazopyridine
8
imidazopyridine imidazopyridazine
8
imidazopyridazine derivatives
8
derivatives dgat2
8
dgat2 inhibitors
8
treating multiple
8
multiple diseases
8
inhibitors treating
4
diseases provided
4
provided novel
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!